Victoria Socha

DocwireNews

Due to the critical physiological role of potassium, development of&nbsp; hyperkalemia requires effective management designed to reduce complications that include muscle weakness, paralysis, and <a href="https://www.docwirenews.com/cardiology/major-adverse-cv-event-risk-reduced-with-sglt2-inhibitors/">cardiac</a> arrhythmias. Patricia Campbell, MD, and colleagues at several hospitals in Northern Ireland, took part in a roundtable discussion on guidance for the use of potassium binders in patients with heart failure and/or chronic kidney disease (CKD). The discussion was <a href="https://www.magonlinelibrary.com/doi/full/10.12968/hmed.2021.0215">reported</a> online in the British Journal of Hospital Medicine [doi.org/10.12968/hmed.2021.0215].Hyperkalemia commonly results from the failure of renal adaption to an imbalance of potassium. Patients with heart failure and those with CKD are particularly susceptible to the development of hyperkalemia. Individuals in those patient populations are often treated with renin-angiotensin- aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers.However, the development of hyperkalemia may require down-titration or discontinuation of RAAS inhibitors, presenting nephrologists, cardiologists, and healthcare professionals treating patients with heart failure and/or CKD with significant challenges.The roundtable discussion centered on the panelists&rsquo; clinical experience using potassium binders in the management of hyperkalemia in Northern Ireland in patients with heart failure and/or CKD. The discussion included case studies as well as recommendations for the implementation and maintenance of chronic potassium-lowering treatment.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Management of Hyperkalemia: Clinical Experiences in Northern Ireland

Hyperkalemia

Due to the critical physiological role of potassium, development of  hyperkalemia requires effective management designed to reduce complications that include muscle weakness, ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe